# Triple-negative breast cancer at Helen Joseph Hospital: Prevalence, age and imaging features

**Authors:** Tsholofelo Zondi, Grace Rubin, Carol-Ann Benn, Sharadini K. Gounden

PMC · DOI: 10.4102/sajr.v29i1.3247 · SA Journal of Radiology · 2025-10-16

## TL;DR

This study examines triple-negative breast cancer at a South African hospital, finding it accounts for 17% of cases and shows unique imaging and biological features.

## Contribution

The study provides new local data on TNBC prevalence, age trends, and imaging patterns in a South African public healthcare setting.

## Key findings

- TNBC accounted for 17% of breast cancer cases, with lesions typically measuring 1–5 cm and showing nodal involvement in 73% of cases.
- TNBC had the highest mean Ki-67 index at 52%, indicating aggressive biology, though some cases showed lower indices, highlighting subtype heterogeneity.

## Abstract

Triple-negative breast cancer (TNBC) is considered an aggressive subtype, defined by the absence of oestrogen, progesterone and HER2 receptors. It typically presents earlier and more aggressively. Limited data exist on its prevalence, age of onset and imaging features in South Africa.

This study aimed to assess the prevalence of TNBC at Helen Joseph Tertiary Hospital (HJTH), describe its histopathological features and explore trends in age at diagnosis and imaging patterns—including early-onset disease.

A retrospective review of 280 female patients with histologically confirmed breast cancer, diagnosed between January 2021 and December 2023, was conducted. Demographic, imaging and histopathology data were analysed using descriptive statistics and chi-square tests.

The diagnosis of TNBC accounted for 17% (48/280) of all breast cancer cases in the cohort. The TNBC lesions typically measured 1–5 cm and showed nodal involvement in 73% of cases. Despite their aggressive biology, many TNBC lesions appeared circumscribed or only mildly irregular on imaging, mimicking benign masses. Among all the 280 breast cancer cases, 61% were high-grade. The mean Ki-67 index for TNBC was the highest at 52%, followed by HER2+ (39%), Luminal B (33%) and Luminal A (21%). Notably, some HER2+ and TNBC cases exhibited lower Ki-67 indices, highlighting heterogeneity within these subtypes.

This study highlights the complexity of breast cancer presentation in a South African setting, particularly the discordance between tumour biology and imaging.

These findings contribute local data on TNBC in an urban public healthcare context, supporting improved imaging awareness and clinical vigilance in resource-limited settings.

## Linked entities

- **Proteins:** ERBB2 (erb-b2 receptor tyrosine kinase 2)
- **Diseases:** breast cancer (MONDO:0004989), triple-negative breast cancer (MONDO:0005494)

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** nodal (MESH:D013611), TNBC (MESH:D064726), breast cancer (MESH:D001943), tumour (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12587192/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12587192/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12587192/full.md

---
Source: https://tomesphere.com/paper/PMC12587192